Varicella Zoster Virus Infection Clinical Trial
Official title:
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
This is an interventional study of vaccination related to infection with varicella zoster virus. We will enroll participants of two age groups. Cohort 1 will be persons between the ages of 30-40; Cohort 2 will be persons who are 70 years of age or older. All participants will receive the FDA-approved recombinant zoster (RZV) vaccine (Shingrix) given at the approved dose and schedule. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01682109 -
Palatability Testing of a New Paediatric Formulation of Valacyclovir
|
Phase 4 | |
| Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
| Recruiting |
NCT05604911 -
Herpes Virus Infections in Kidney Transplant Patients
|
||
| Recruiting |
NCT05532540 -
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
|
||
| Not yet recruiting |
NCT05664152 -
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
|
N/A | |
| Completed |
NCT01689285 -
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
|
Phase 1 | |
| Terminated |
NCT04081480 -
Pharmacokinetics of Valacyclovir Oral Solution in Children
|
N/A |